Treatment of heparin-induced thrombocytopenia.
Greinacher
A
A
Institute for Immunology and Transfusion Medicine, Ernst-Moritz-Arndt-University, Greifswald, Germany. greinach@mail.uni-greifswald.de
D000328:Adult; D000721:Ancrod / Q000276:immunology / Q000627:therapeutic use; D000906:Antibodies; D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D000936:Antigen-Antibody Complex; D000991:Antithrombins / Q000276:immunology / Q000627:therapeutic use*; D002648:Child; D002809:Chondroitin Sulfates / Q000276:immunology / Q000627:therapeutic use; D003429:Cross Reactions; D003871:Dermatan Sulfate / Q000276:immunology / Q000627:therapeutic use; D004338:Drug Combinations; D005112:Extracorporeal Circulation; D005260:Female; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006497:Heparan Sulfate / Q000276:immunology / Q000627:therapeutic use; D024764:Hirudin Therapy; D006629:Hirudins / Q000276:immunology; D006801:Humans; D010978:Platelet Factor 4 / Q000276:immunology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy* / Q000276:immunology; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000139:chemically induced / Q000188:drug therapy
D000721:Ancrod; D000906:Antibodies; D000925:Anticoagulants; D000936:Antigen-Antibody Complex; D000991:Antithrombins; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006493:Heparin; D006497:Heparan Sulfate; D006629:Hirudins; D010978:Platelet Factor 4; C035838:danaparoid